Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change disease.
Saved in:
| Title: | Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change disease. |
|---|---|
| Authors: | Crompton M; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Ramnath RD; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Betteridge K; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Desideri S; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Alonso AM; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Jiang L; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Gamez M; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Stowell-Connolly H; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Vasylchenko V; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Onions KL; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Butler MJ; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Neal CR; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Salmon AHJ; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Turnbull JE; Copenhagen Centre for Glycomics, Institute of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark., Kawachi H; Department of Cell Biology, Institute of Nephrology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Zubkova OV; Ferrier Research Institute, Victoria University of Wellington, Wellington, New Zealand., Welsh GI; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Satchell SC; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Foster RR; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK. |
| Source: | Clinical and translational medicine [Clin Transl Med] 2026 Jun; Vol. 16 (6), pp. e70706. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326 (Electronic) Linking ISSN: 20011326 NLM ISO Abbreviation: Clin Transl Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2001-1326 |
|---|---|
| DOI: | 10.1002/ctm2.70706 |
